Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on April 16, 2013, covering events occurring on April 10 and April 12, 2013. The filing addresses changes to the Company's Board of Directors, specifically the resignation of a director and the election of a new director.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and director compensation arrangements.
Material Changes
- Resignation of Director: Bruce C. Conway resigned from the Board of Directors and the Compensation Committee effective April 12, 2013. The resignation was voluntary to facilitate the appointment of a new director and was not due to any disagreement with the Company.
- Election of New Director: Philip A. Pizzo, M.D., was elected to the Board on April 12, 2013, to serve until the 2013 annual meeting of stockholders. He was immediately appointed to the Compensation Committee.
- Compensation Adjustments:
- Mr. Conway's vesting of 45,000 shares under a stock option granted in April 2012 was accelerated in recognition of his service.
- Dr. Pizzo was granted an option to purchase 45,000 shares of common stock, vesting in equal annual installments over three years.
- Dr. Pizzo is entitled to an annual retainer of $15,000, a $3,000 supplemental retainer for the Compensation Committee, and meeting fees of $1,000 (in-person) or $500 (telephone).
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. Management commentary is limited to the rationale for the board changes, noting that Dr. Pizzo's extensive medical leadership experience will strengthen the Board. The Company entered into a standard indemnification agreement with Dr. Pizzo, covering legal expenses and judgments arising from his service as a director.
Investor Verification Checklist
- Verify the effective date of Bruce C. Conway's resignation (April 12, 2013) and the acceleration of his 45,000 share option vesting.
- Confirm the terms of Dr. Pizzo's compensation, including the $15,000 annual retainer, committee fees, and the vesting schedule for his initial 45,000 share option.
- Review the standard indemnification agreement (Exhibit 10.1) to understand the extent of liability protection provided to the new director.
- Note that the filing references a press release dated April 16, 2013 (Exhibit 99.1) for public announcement details.